11/17/2014 - 6:45pm

Thirty years ago, Democratic and Republican members of Congress hammered out a rare and prescient bipartisan compromise bill that transformed the pharmaceutical landscape forever and unleashed the modern generic drug industry. That law, known as the Hatch-Waxman Act, has proven to be one of the most far-reaching and impactful pieces of legislation ever to shape the American healthcare system.

11/17/2014 - 1:40pm

People who received automated reminders were more likely to refill their blood-pressure and cholesterol medications, according to a study published in the American Journal of Managed Care.

11/17/2014 - 1:16pm

CRN on Monday submitted comments to the Food and Drug Administration advocating a new qualified health claim for EPA+DHA and blood-pressure reduction. 

11/17/2014 - 10:24am

Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock, the company announced Monday.

11/17/2014 - 9:54am

Genzyme, a Sanofi company, on Friday announced that the Food and Drug Administration approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis. 

11/17/2014 - 9:39am

Target and Kaiser Permanente are teaming up to launch in Southern California four Target Clinics that will feature expanded services not typically available in Target Clinics.

11/14/2014 - 10:23am

Almost 23% of high school students currently use a tobacco product, according to new data published by the Centers for Disease Control and Prevention.

 

11/14/2014 - 10:07am

Each year Americans make nearly a million doctor visits for eye infections, resulting in $175 million in direct healthcare costs, the Centers for Disease Control and Prevention estimated.

11/14/2014 - 9:57am

The Healthy Communities Institute on Thursday introduced the SocioNeeds Index, which identifies those living in the highest risk zip codes that can benefit most from supportive health and social programs.